003090 — Daewoong Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapSuper Stock

Market Cap
KR₩757bn
Enterprise Value
KR₩1tn
Revenue
KR₩2tn

Annual income statement for Daewoong Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	R2019 December 31st	2020 December 31st	R2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	1,365,679	1,355,337	1,511,374	1,697,338	1,813,841
Cost of Revenue
Gross Profit	633,387	626,457	763,000	899,652	931,247
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	1,272,454	1,266,597	1,331,014	1,494,947	1,595,534
Operating Profit	93,226	88,740	180,360	202,392	218,307
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	80,090	144,617	113,212	154,932	202,522
Provision for Income Taxes
Net Income After Taxes	70,396	118,380	99,784	120,268	191,439
Minority Interest
Net Income Before Extraordinary Items
Net Income	61,493	98,379	78,730	102,566	152,665
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	61,493	98,379	78,730	102,566	152,665
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	1,687	2,539	1,966	2,580	3,221
Dividends per Share